In conclusion, in this single-institution retrospective cohort review of 490 consecutively newly diagnosed patients with glioblastoma, IDH-wildtype, CNS WHO grade 4, and astrocytoma, IDH-mutant, CNS WHO grade 4, the median survival from diagnosis was 9.2 months. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).